Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	391.50	116.82	23.77
Graham Fair Price	-61.26	43.81	113.07
PEG	3049.40	-1.40	0.04
Price/Book	81.98	6.84	3.76
Price/Cash Flow	600.52	-108.57	15.50
Prices/Earnings	1137.11	119.31	9.64
Price/Sales	197.45	14.49	4.87
Price/FCF	600.52	-108.57	15.50
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-31.57	0.19	0.28
Operating Margin	-59.72	0.07	0.18
ROA	-84.69	< 0.005	0.03
ROE	0.10	0.01	-85.29
ROIC	0.07	0.01	-79.81
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.07	-0.22	69.97
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.66	-0.75	-54.83
EPS QOQ	2.17	-0.85	-60.72
FCF QOQ	8.88	-1.26	-85.79
Revenue QOQ	0.46	-0.38	-16.07
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	158.33	271.55	71.51
Days Sales Outstanding (DSO)	94.15	119.37	26.79
Inventory Turnover	0.57	0.33	-41.69
Debt/Capitalization	0.34	0.35	3.20
Quick Ratio	0.66	0.49	-25.35
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	76.37	77.15	1.02
Cash	21.07	11.86	-43.72
Capex	-3.78	-2.42	35.98
Free Cash Flow	18.52	-4.86	-73.76
Revenue	58.92	36.41	-38.20
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.30	1.31	0.62
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.87	6.15	229.18
Naive Interpretation	Member

06 - Financial Health · Weak

Rating